Abstracts

Impact of acute-on-chronic liver failure (ACLF) on response to treatment with terlipressin and albumin in patients with type 1 hepatorenal syndrome

Piano S, Schmidt H, Ariza X, Amorós A, Romano A, Solà E, Gerbes A, Bernardi M, Alessandria C, Trebicka J, Gustot T, Nevens F, Arroyo V, Ginés P, Angeli P.

In Book of Abstract: 50th AISF Annual Meeting, Associazione Italiana per lo Studio del Fegato (AISF), 23–24 February 2017, Rome, Italy.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others

Impact of acute-on-chronic liver failure (ACLF) on response to treatment with terlipressin and albumin in patients with type 1 hepatorenal syndrome

Registered office

Legal

Contact us

Abstracts

Impact of acute-on-chronic liver failure (ACLF) on response to treatment with terlipressin and albumin in patients with type 1 hepatorenal syndrome

Registered office

Legal

Contact us

We value your privacy